Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis
Fecal biomarkers were correlated with endoscopic activity and effectively identified patients with endoscopically active IMDC. Our findings suggest that these biomarkers may be valuable tools for the diagnosis and assessment of treatment response in IMDC.
Authors
- K Takenaka (ORCID: https://orcid.org/0000-0002-7861-8383)
- Shuji Hibiya (ORCID: https://orcid.org/0000-0001-8823-7755)
- Ami Kawamoto (ORCID: https://orcid.org/0000-0002-8549-4999)
- Yasuo Hamamoto (ORCID: https://orcid.org/0000-0002-5737-122X)
- Yoshihito Kano (ORCID: https://orcid.org/0000-0001-7511-7009)
- Toshimitsu Fujii (ORCID: https://orcid.org/0000-0003-3048-7270)
- Ryo Morikawa
- Hiromichi Shimizu (ORCID: https://orcid.org/0000-0003-3268-0613)
- Kazuo Ohtsuka (ORCID: https://orcid.org/0000-0002-2409-9709)
- Mitsukuni Suenaga
- Ryuichi Okamoto (ORCID: https://orcid.org/0000-0002-7047-571X)
- Akiko Tamura
Institutions
- Tokyo Metropolitan Institute of Medical Science (JP)
- Temple University, Japan (JP)
Publication Details
- Journal
- Digestion
- Published
- 2025-12-06
- DOI
- https://doi.org/10.1159/000549888
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00